SciSparc Ltd. (Nasdaq: SPRC) ('Company” or 'SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ('NeuroThera') ...

Now that we've unpacked some iconic tagline examples, let's take a second to savour what makes them so deliciously effective at sticking around. Have you ever heard those slogans that never seem to ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their launch of ‘Human Data Trials' - a new category of pre-clinical research ...

Let's be honest, we're all drama queens sometimes. Whether you're texting your bestie you're “literally dying” over the latest celebrity gossip or declaring on social media that Monday mornings are ...

When President Trump fired the head of the Bureau of Labor Statistics, it set off worries that economic data might not be as trustworthy in the future. The president claimed, without citing evidence, ...

Tourmaline Bio's lead asset, Pacibekitug, targets IL-6 for inflammatory and autoimmune diseases, showing promise in ASCVD, TED, and AAA with upcoming pivotal data. Pacibekitug's subcutaneous dosing ...

This Research Topic is currently accepting articles. In the rapidly evolving field of computational intelligence, there is a pressing demand for advanced tools and algorithms that can significantly ...

An experimental cellular medicine developed by Orca Bio outperformed a standard stem cell transplant in treating people with several types of blood cancer by helping avert a potentially dangerous side ...

PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma NfL levels, a disease progression biomarker, compared to published natural history data Evaluating Dose ...

As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights ...

This repository is a starting point for developers looking to integrate with the NVIDIA software ecosystem to speed up their generative AI systems. Whether you are building RAG pipelines, agentic ...

In advanced non-small cell lung cancer, Summit Therapeutics’ ivonescimab appears to be 49% more effective at reducing the risk of disease progression or death versus Merck’s Keytruda in a late-stage ...